Literature DB >> 17888775

Interventional breast imaging: current procedures and assessing for concordance with pathology.

Lawrence W Bassett1, Mary C Mahoney, Sophia K Apple.   

Abstract

Minimally invasive breast biopsy procedures performed for suspicious imaging findings have expanded the role of breast imaging in the management of breast diseases. The first portion of this article reviews the current procedures for performing a core-needle biopsy under stereotactic, ultrasound, and MR imaging guidance. The second portion of the article addresses the management of the patient after the biopsy, including assessment for concordance of radiology and pathology findings and potential underestimation of disease.

Entities:  

Mesh:

Year:  2007        PMID: 17888775     DOI: 10.1016/j.rcl.2007.06.010

Source DB:  PubMed          Journal:  Radiol Clin North Am        ISSN: 0033-8389            Impact factor:   2.303


  13 in total

1.  Recurrent Mastitis after Core Needle Biopsy: Case Report of an Unusual Complication after Core Needle Biopsy of a Phyllodes Tumor.

Authors:  Nikola Kasprowicz; Gerd J Bauerschmitz; Alexandra Schönherr; Stephan E Baldus; Wolfgang Janni; Svjetlana Mohrmann
Journal:  Breast Care (Basel)       Date:  2012-06-22       Impact factor: 2.860

Review 2.  Concordant or discordant? Imaging-pathology correlation in a sonography-guided core needle biopsy of a breast lesion.

Authors:  Ji Hyun Youk; Eun-Kyung Kim; Min Jung Kim; Kyung Hee Ko; Jin Young Kwak; Eun Ju Son; Junjeong Choi; Hae Youn Kang
Journal:  Korean J Radiol       Date:  2011-03-03       Impact factor: 3.500

3.  Analysis of false-negative results after US-guided 14-gauge core needle breast biopsy.

Authors:  Ji Hyun Youk; Eun-Kyung Kim; Min Jung Kim; Jin Young Kwak; Eun Ju Son
Journal:  Eur Radiol       Date:  2009-10-28       Impact factor: 5.315

Review 4.  Short-term imaging follow-up of patients with concordant benign breast core needle biopsies: is it really worth it?

Authors:  Michelle C Adams; Shannon Falcon; Blaise P Mooney; Christine Laronga; Alec Chau; Jennifer S Drukteinis
Journal:  Diagn Interv Radiol       Date:  2014-11       Impact factor: 2.630

5.  HR-MAS MR spectroscopy of breast cancer tissue obtained with core needle biopsy: correlation with prognostic factors.

Authors:  Ji Soo Choi; Hyeon-Man Baek; Suhkmann Kim; Min Jung Kim; Ji Hyun Youk; Hee Jung Moon; Eun-Kyung Kim; Kyung Hwa Han; Dong-Hyun Kim; Seung Il Kim; Ja Seung Koo
Journal:  PLoS One       Date:  2012-12-14       Impact factor: 3.240

6.  Evolving concepts in breast lobular neoplasia and invasive lobular carcinoma, and their impact on imaging methods.

Authors:  Tatiane M G Oliveira; Jorge Elias; Andrea F Melo; Sara R Teixeira; Salomão C Filho; Larissa M Gonçalves; Francesca M Faria; Daniel G Tiezzi; Jurandyr M Andrade; Valdair Muglia
Journal:  Insights Imaging       Date:  2014-03-16

7.  Imaging-cytology correlation of thyroid nodules with initially benign cytology.

Authors:  Shin Hye Hwang; Ji Min Sung; Eun-Kyung Kim; Hee Jung Moon; Jin Young Kwak
Journal:  Int J Endocrinol       Date:  2014-10-13       Impact factor: 3.257

8.  Ductal Carcinoma in situ: Underestimation of Percutaneous Biopsy and Positivity of Sentinel Lymph Node Biopsy in a Brazilian Public Hospital.

Authors:  Rafael da Silva Sá; Angela Flávia Logullo; Simone Elias; Gil Facina; Vanessa Monteiro Sanvido; Afonso Celso Pinto Nazário
Journal:  Breast Cancer (Dove Med Press)       Date:  2021-06-21

9.  Axillary Nodal Metastases from Carcinoma of Unknown Primary (CUPAx): Role of Contrast-Enhanced Spectral Mammography (CESM) in Detecting Occult Breast Cancer.

Authors:  Melania Costantini; Rino Aldo Montella; Maria Paola Fadda; Giorgia Garganese; Alba Di Leone; Alejandro Martin Sanchez; Gianluca Franceschini; Pierluigi Maria Rinaldi
Journal:  J Pers Med       Date:  2021-05-25

10.  Magnetic resonance metabolic profiling of breast cancer tissue obtained with core needle biopsy for predicting pathologic response to neoadjuvant chemotherapy.

Authors:  Ji Soo Choi; Hyeon-Man Baek; Suhkmann Kim; Min Jung Kim; Ji Hyun Youk; Hee Jung Moon; Eun-Kyung Kim; Youn Ki Nam
Journal:  PLoS One       Date:  2013-12-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.